Trials Without Borders is a multi-episode webinar series hosted by Dan Schell, chief editor of Clinical Leader, and Elena Sinclair, principal consultant at FlexPoint Bio. The series will address the challenges and benefits of running clinical trials in countries such as Australia and Canada and include interviews with SMEs who have experience with these types of trials.
TRIALS WITHOUT BORDERS: EPISODE I
Trials Without Borders: A Webinar Series From Clinical Leader And FlexPoint Bio
Trials Without Borders is a multi-episode webinar series hosted by Dan Schell, chief editor of Clinical Leader, and Elena Sinclair, principal consultant at FlexPoint Bio. The series will address the challenges and benefits of running clinical trials in countries such as A...
TRIALS WITHOUT BORDERS: EPISODE II
Trials Without Borders: Regulatory & Site Landscapes
Experts Megan Robertson and Tina Soulis, Ph.D. discuss the regulatory and ethical landscape for conducting clinical trials in Australia. Topics covered include everything from CTA/IND submission processes and EC/IRB review timelines to ICH E6(R3) alignment and decentraliz...
TRIALS WITHOUT BORDERS: EPISODE III
Trials Without Borders: Financial Considerations & Cultural Realities
This episode of Trials Without Borders features executives from Etira, a biopharma focused on oncology treatments. The panelists discuss the realities of running clinical trials in Australia, covering financial incentives, regulatory processes, cultural collaboration, pat...
MEET OUR HOSTS
Dan Schell is Chief Editor of Clinical Leader where he writes about topics related to clinical trial operations. Previously, he served as the Editorial Director of Life Science Leader magazine where he worked with writers and editors on choosing the best topics for articles as well as refining all content to meet the publication's high editorial standards.
Elena "Ella" Sinclair is the Founder and CEO of FlexPoint Bio, a consulting firm specializing in biomarker and biospecimen strategy, logistics, and clinical outsourcing. With over 20 years of experience spanning bench research, site-level operations, and sponsor-side clinical trials, Ella brings a holistic perspective to clinical development. Passionate about ethical and innovative AI implementation, she drives lean, technology-driven clinical trials that aim to deliver treatments to patients faster, safer, and more reliably.